Salivary gland disease in human immunodeficiency virus-positive women from the WIHS study

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 89, Issue 6, 2000, Pages 702-709

  Mulligan, Roseann ^a   Navazesh, Mahvash ^a   Komaroff, Eugene ^b   Greenspan, Deborah ^c   Redford, Maryann ^d   Alves, Mario ^e   Phelan, Joan ^f  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Natl Institutes Dent C   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOLOGY; INTERVIEW; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; SALIVARY GLAND DISEASE; SERODIAGNOSIS; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HEALTH STATUS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HIV-1; HUMANS; INTERVIEWS; MIDDLE AGED; SALIVARY GLAND DISEASES; UNITED STATES;

EID: 0034199951     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2000.105328     Document Type: Article

References (41)

1. Ryan JR, Ioachim HL, Marmer J, Loubeau JM. Acquired immune deficiency syndrome-related lymphadenopathies presenting in the salivary gland lymph nodes. Arch Otolaryngol 1985;111:554-6.
2. Schiodt M. HI V-associated salivary gland disease: a review. Oral Surg Oral Med Oral Path 1992;73:164-7.
3. Weinert M, Grimes RM, Lynch DP. Oral manifestations of HIV infection. Ann Intern Med 1996;125:485-96.
4. Atkinson JC, Yeh C-K, Bermudez D, Fox PC, Baum BJ. Longitudinal evaluation of major salivary gland function in HIV-1 infected patienta. J Oral Pathol Med 1989;18:469-70.
5. Roberts MW, Brahim JS, Rinne NF. Oral manifestations of AIDS: a study of 84 patienta. J Am Dent Assoc 1988;116:863-6.
6. Mirowski GW, Greenspan D, Hilton JF, Canchola AJ, Macphail LA, Maurer T, et al. Co-prevalence of cutaneous and oral diseasesin HIV-positive patients [abstract No. 1768]. J Den Res 1996;75:238.
7. Blignaut E, Glick M. Oral complications in South African HIV/AIDS patients [abstract No. 3128]. J Den Res1997;76:404.
8. Casariego Z, Cahn P, Perez H, Casiró A, Grinberg N, Muchinik G, et al. Oral pathology in 105 reactive patients in Buenos Aires Int Conf AIDS [abstract No. MBO16]. Jun 4-9, 1989;5:190.
9. Magaruka Z, Perriens J, Ngaly B, Baende E, Kahotwa J, Kapita B. Oral manifestations of HIV infection in African patients [abstract No. MBO17]. Int Conf AIDS; 1989 Jun 4-9, 1989;5;190.
10. Shiboski CH, Hilton JF, Neuhaus JM, Canchola A, Greenspan D. Human immunodeficiency virus-related oral manifestations and gender. Arch Intern Med 1996;156:2249-54.
11. Mandel ID, Barr CE, Turgeon L. Longitudinal study of parotid saliva in HIV infection [abstract]. J Dent Res 1991;70:287.
12. Schiodt M, Greenspan D, Daniels TE, Nelson J, Leggott PJ, Wara DW, et al. Parotid gland enl argement and xerostomi a associated with labial sialadenitis in HIV-infected patients. J Autoimmun 1989;2:415-25.
13. Gottesman RI, Som PM, Mester J, Silvers A R. Observations on two cases of apparent submandibular gland cysts in HIV positive patienta MR and CT findings. J Comput Aasist Tomogr 1996;20:444-447.
14. Itescu S, Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheum Dis Clin North Am 1992;18:683-97.
15. Kazi S, Cohen PR, Williams F, Schempp R, Reveille JD. The diffuse infiltrative lymphocytosis syndrome: clinical and immunogenetic features in 35 patienta. AIDS 1996;10:385-91.
16. Jarrousse B, Lortholary O, Cohen P, Zeller V, Berlureau P, Arene JP, et al. Symptomatic systemic CDS lymphocytosis in HIV-1 infection: a cohort study [abstract No. Mo.B1282]. Int Conf AIDS Jul 7-12, 1996;11:103.
17. Itescu, S, Brancato LJ, Winchester R. A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 1989;8661:466-48.
18. Mandel L, Kim D, and Uy C. Parotid swelling in HIV diffuse infiltrative CD8 lymphocytosis syndrome 1998;85:565-8.
19. Chapnik JS, Noyek AM, Berris B, Wortzman G, Simor AE, Houpt JB, et al. Parotid gland enlargement in HIV infection: clinical/imaging findinga. J Otolaryngol 1990;19:189-94.
20. Tao L, Gullane PJ. HIV infection-associated lymphoepithelial lesions of the parotid gland: aspiration biopsy cytology, histology and pathogenesis. Diagn Cytopathol 1991;7:158-62.
21. Sperling NM, Lin P, Lucente FE. Cystic parotid masses in HIV infection. Head Neck 1990;12:337-41.
22. Ioachim HL, Ryan JR, Blaugrund SM. Salivary gland lymph nodes. Arch Pathol Lab Med 1988;112:1224-8.
23. Terry JH, Loree TR, Thomas MD, Marti JR. Major salivary gland lymphoepithelial lesions and the acquired immunodeficiency syndrome. Am J Surg 1991;162:324-9.
24. Schrot RJ, Adelman HM, Linden CN, Wallach PM. Cystic parotid gland enlargement in HIV disease (photo/essay). JAMA 1997;278:166-7.
25. Yeh C, Fox PC, Ship JA, Busch KA, Bermudez DK, Wilder A, et al. Oral defense mechanisms are impaired early in HIV-1 infected patienta. JAcquir Immune Defic Syndr 1988;1:361-6.
26. Scully C, Laskaris G, Pindborg J, Porter SR, Raichart P. Oral manifestations of HIV infection and their management. II. Less common lesions. Oral Surg Oral Med Oral Pathol 1991;71:167-71.
27. DiGiuseppe JA, Corio RL, Westra WH. Lymphoid infiltrates of the salivary glands pathology, biology and clinical significance. Curr Opin Oncol 1996;8:232-7.
28. Scully C, Flint SR, Porter SR. Oral diseases. 2nd ed. St Louis Mosby; 1996. p. 204.
29. Regezi JA, Sciubba JJ, editors. Oral pathology clinical pathologic correlations 3rd ed. Philadelphia: WB Saunders; 1999. p. 232.
30. Smith RG. Oral side effects of the most frequently prescribed drugs. Spec Care Dentist 1994;14:96-102.
31. Lamey PJ. Salivary gland and chemosensory disorders: Review of the literature. In: Millard HD, editor. Second world workshop on oral medicine. Ann Arbor (MI): University of Michigan; 1995. p. 273-335.
32. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The women's interagency HIV study. Epidemiology 1998;9:117-25.
33. Brunelle JA, Redford M, Doherty I, Nelson K, Mulligan RA, Greenspan JS, et al. Women's interagency HIV study oral protocol: design, methods and sample characteristics [Abstract]. J Dent Res 1998;77:155.
34. Seidel HM, Ball JW, Dains JE, Benedict GW. Mosby's guide to physical examination. 4th ed. St Louis Mosby; 1999. p. 53.
35. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992;71:1363-9.
36. CDC1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults No. RR-17. MMWR 1992;41.
37. Wiltshire A, Flaitz M, Nichols M, Hicks J. Prevalence of HIV-associated oral disease in women. J Dent Res 1996;75:239.
38. Patton LL, Mckaig RG, Strauss RP, Eron JJ. Gender, race, risk, CD4: Associations with oral manifestations of HIV. J Dent Res 1997;76:262.
39. Williams FM, Cohen PR, Jumshyd J, Reveille. Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virustype-1 positive outpatients. Arthritis & Rheum 1998;41:863-8.
40. Schiodt M, Greenspan D, Levy JA, Nelson JA, Chernoff D, Hollander H, et al. Does HIV cause salivary gland disease? AIDS 1989;3:819-22.
41. Korchma E, Lelkes M, Banhegyi J, Szlavik J. Follow up of oral manifestations in HIV/AIDS in Hungary [abstract No. 32251]. Int Conf AIDS; 1998 Jun 28-Jul 3.